Reckitt Benckiser Group (3RB.DE) Stock Analysis & Winston Score

Reckitt Benckiser is a British consumer goods company that makes health, hygiene, and nutrition products sold in homes around the world. Its brands include Dettol, Lysol, Durex, Nurofen, Strepsils, and Enfamil infant formula. The company sells mostly to everyday consumers through supermarkets, pharmacies, and online retailers. Reckitt earns money by selling these branded products directly to retailers, who then sell them to shoppers. It operates in over 60 countries, with strong sales across North America, Europe, and emerging markets, generating roughly $15 billion in annual revenue. Its main competitive advantage is its portfolio of trusted, well-known brands that consumers repeatedly buy out of habit — making it hard for cheaper store-brand alternatives to fully displace them. The biggest risk the company faces is ongoing legal and reputational pressure tied to its Enfamil infant formula business, where lawsuits allege links between the product and a serious intestinal condition in premature babies, which could result in significant financial liability.